{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:50:23Z","timestamp":1771663823151,"version":"3.50.1"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T00:00:00Z","timestamp":1426723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00436-015-4423-1","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T02:13:43Z","timestamp":1426644823000},"page":"1647-1659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Understanding drug resistance in human intestinal protozoa"],"prefix":"10.1007","volume":"114","author":[{"given":"Hend Aly","family":"El-Taweel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,19]]},"reference":[{"key":"4423_CR1","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1086\/320751","volume":"32","author":"P Abboud","year":"2001","unstructured":"Abboud P, Lem\u00e9e V, Gargala G, Brasseur P, Ballet JJ, Borsa-Lebas F, Caron F, Favennec L (2001) Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 32:1792\u20131794","journal-title":"Clin Infect Dis"},{"key":"4423_CR2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/49.1.103","volume":"49","author":"IS Adagu","year":"2002","unstructured":"Adagu IS, Nolder D, Warhurst DC, Rossignol JF (2002) In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J Antimicrob Chemother 49:103\u2013111","journal-title":"J Antimicrob Chemother"},{"key":"4423_CR3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1874104501105010040","volume":"5","author":"Y Alfonso","year":"2011","unstructured":"Alfonso Y, Monzote L (2011) HIV protease inhibitors: effect on the opportunistic protozoan parasites. Open Med Chem J 5:40\u201350. doi: 10.2174\/1874104501105010040","journal-title":"Open Med Chem J"},{"key":"4423_CR4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.meegid.2008.05.004","volume":"8","author":"IK Ali","year":"2008","unstructured":"Ali IK, Clark CG, Petri WA Jr (2008) Molecular epidemiology of amebiasis. Infect Genet Evol 8:698\u2013707. doi: 10.1016\/j.meegid.2008.05.004","journal-title":"Infect Genet Evol"},{"key":"4423_CR5","first-page":"548","volume":"12","author":"A Alizadeh","year":"2006","unstructured":"Alizadeh A, Ranjbar M, Kashani KM, Taheri MM, Bodaghi M (2006) Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran. East Mediterr Health J 12:548\u2013554","journal-title":"East Mediterr Health J"},{"key":"4423_CR6","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/j.ijid.2009.11.036","volume":"14","author":"A Alum","year":"2010","unstructured":"Alum A, Rubino JR, Ijaz MK (2010) The global war against intestinal parasites\u2014should we use a holistic approach? Int J Infect Dis 14:e732\u2013e738. doi: 10.1016\/j.ijid.2009.11.036","journal-title":"Int J Infect Dis"},{"key":"4423_CR7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.meegid.2009.05.015","volume":"9","author":"R Arg\u00fcello-Garc\u00eda","year":"2009","unstructured":"Arg\u00fcello-Garc\u00eda R, Cruz-Soto M, Romero-Montoya L, Ortega-Pierres G (2009) In vitro resistance to 5-nitroimidazoles and benzimidazoles in Giardia duodenalis: variability and variation in gene expression. Infect Genet Evol 9:1057\u20131064. doi: 10.1016\/j.meegid.2009.05.015","journal-title":"Infect Genet Evol"},{"key":"4423_CR8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1017\/S003118201200011X","volume":"139","author":"S Bagchi","year":"2012","unstructured":"Bagchi S, Oniku AE, Topping K, Mamhoud ZN, Paget TA (2012) Programmed cell death in Giardia. Parasitology 139:894\u2013903. doi: 10.1017\/S003118201200011X","journal-title":"Parasitology"},{"key":"4423_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-0711-3-27","volume":"3","author":"D Bansal","year":"2004","unstructured":"Bansal D, Sehgal R, Chawla Y, Mahajan RC, Malla N (2004) In vitro activity of antiamoebic drugs against clinical isolates of Entamoeba histolytica and Entamoeba dispar. Ann Clin Microbiol Antimicrob 3:27","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"4423_CR10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.26719\/2001.7.4-5.787","volume":"7","author":"R Baqai","year":"2001","unstructured":"Baqai R, Zuberi SJ, Qureshi H, Ahmed W, Hafiz S (2001) Efficacy of albendazole in giardiasis. East Mediterr Health J 7:787\u2013790","journal-title":"East Mediterr Health J"},{"key":"4423_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/gmic.2.1.14755","volume":"2","author":"JL Barratt","year":"2011","unstructured":"Barratt JL, Harkness J, Marriott D, Ellis JT, Stark D (2011) A review of Dientamoeba fragilis carriage in humans: several reasons why this organism should be considered in the diagnosis of gastrointestinal illness. Gut Microbes 2:3\u201312. doi: 10.4161\/gmic.2.1.14755","journal-title":"Gut Microbes"},{"key":"4423_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4269\/ajtmh.2011.10-0580","volume":"84","author":"S Becker","year":"2011","unstructured":"Becker S, Hoffman P, Houpt ER (2011) Efficacy of antiamebic drugs in a mouse model. Am J Trop Med Hyg 84:581\u2013586. doi: 10.4269\/ajtmh. 2011.10-0580","journal-title":"Am J Trop Med Hyg"},{"key":"4423_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2334-13-37","volume":"13","author":"SL Becker","year":"2013","unstructured":"Becker SL, Vogt J, Knopp S, Panning M, Warhurst DC, Polman K, Marti H, von M\u00fcller L, Yansouni CP, Jacobs J, Bottieau E, Sacko M, Rijal S, Meyanti F, Miles MA, Boelaert M, Lutumba P, van Lieshout L, N\u2019Goran EK, Chappuis F, Utzinger J (2013) Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect Dis 13:37. doi: 10.1186\/1471-2334-13-37","journal-title":"BMC Infect Dis"},{"key":"4423_CR14","first-page":"203","volume":"36","author":"AP Bellanger","year":"2013","unstructured":"Bellanger AP, Scherer E, Cazorla A, Grenouillet F (2013) Dysenteric syndrome due to Balantidium coli: a case report. New Microbiol 36:203\u2013205","journal-title":"New Microbiol"},{"key":"4423_CR15","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1017\/S0031182011001223","volume":"138","author":"E B\u00e9n\u00e9r\u00e9","year":"2011","unstructured":"B\u00e9n\u00e9r\u00e9 E, Van Assche T, Cos P, Maes L (2011) Variation in growth and drug susceptibility among Giardia duodenalis assemblages A, B and E in axenic in vitro culture and in the gerbil model. Parasitology 138:1354\u20131361. doi: 10.1017\/S0031182011001223","journal-title":"Parasitology"},{"key":"4423_CR16","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00436-007-0701-x","volume":"101","author":"AJ Benitez","year":"2007","unstructured":"Benitez AJ, McNair N, Mead J (2007) Modulation of gene expression of three Cryptosporidium parvum ATP-binding cassette transporters in response to drug treatment. Parasitol Res 101:1611\u20131616","journal-title":"Parasitol Res"},{"key":"4423_CR17","first-page":"241","volume":"36","author":"R Bernal-Redondo","year":"2004","unstructured":"Bernal-Redondo R, Mart\u00ednez-M\u00e9ndez LG, Mendoza-Chavez A, Velasco-Perales D, Chavez-Munguia B (2004) Evaluation of the in vitro effect of albendazole, metronidazole and nitazoxanide on viability and structure of Giardia lamblia cysts. J Submicrosc Cytol Pathol 36:241\u2013245","journal-title":"J Submicrosc Cytol Pathol"},{"key":"4423_CR18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4269\/ajtmh.2001.65.94","volume":"65","author":"R Bialek","year":"2001","unstructured":"Bialek R, Overkamp D, Rettig I, Knobloch J (2001) Case report: nitazoxanide treatment failure in chronic isosporiasis. Am J Trop Med Hyg 65:94\u201395","journal-title":"Am J Trop Med Hyg"},{"key":"4423_CR19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.exppara.2004.03.012","volume":"106","author":"MT Bonafonte","year":"2004","unstructured":"Bonafonte MT, Romagnoli PA, McNair N, Shaw AP, Scanlon M, Leitch GJ, Mead JR (2004) Cryptosporidium parvum: effect of multi-drug reversing agents on the expression and function of ATP-binding cassette transporters. Exp Parasitol 106:126\u2013134","journal-title":"Exp Parasitol"},{"key":"4423_CR20","doi-asserted-by":"crossref","first-page":"e42844","DOI":"10.1371\/journal.pone.0042844","volume":"7","author":"TH Boyles","year":"2012","unstructured":"Boyles TH, Black J, Meintjes G, Mendelson M (2012) Failure to eradicate Isospora belli diarrhoea despite immune reconstitution in adults with HIV\u2014a case series. PLoS One 7:e42844. doi: 10.1371\/journal.pone.0042844","journal-title":"PLoS One"},{"key":"4423_CR21","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1185\/030079906X132497","volume":"22","author":"R Ca\u00f1ete","year":"2006","unstructured":"Ca\u00f1ete R, Escobedo AA, Gonz\u00e1lez ME, Almirall P, Cantelar N (2006) A randomized, controlled, open-label trial of a single day of mebendazole versus a single dose of tinidazole in the treatment of giardiasis in children. Curr Med Res Opin 22:2131\u20132136","journal-title":"Curr Med Res Opin"},{"key":"4423_CR22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1574-6976.2011.00295.x","volume":"35","author":"R Cant\u00f3n","year":"2011","unstructured":"Cant\u00f3n R, Morosini MI (2011) Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev 35:977\u2013991. doi: 10.1111\/j.1574-6976.2011.00295.x","journal-title":"FEMS Microbiol Rev"},{"key":"4423_CR23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1550-7408.2002.tb00523.x","volume":"49","author":"R Cedillo-Rivera","year":"2002","unstructured":"Cedillo-Rivera R, Ch\u00e1vez B, Gonz\u00e1lez-Robles A, Tapia A, Y\u00e9pez-Mulia L (2002) In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites. J Eukaryot Microbiol 49:201\u2013208","journal-title":"J Eukaryot Microbiol"},{"key":"4423_CR24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/cid\/cir810","volume":"54","author":"CM Coyle","year":"2012","unstructured":"Coyle CM, Varughese J, Weiss LM, Tanowitz HB (2012) Blastocystis: to treat or not to treat\u2026. Clin Infect Dis 54:105\u2013110. doi: 10.1093\/cid\/cir810","journal-title":"Clin Infect Dis"},{"key":"4423_CR25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2958.2000.01863.x","volume":"36","author":"M Dan","year":"2000","unstructured":"Dan M, Wang AL, Wang CC (2000) Inhibition of pyruvate-ferredoxin oxidoreductase gene expression in Giardia lamblia by a virus-mediated hammerhead ribozyme. Mol Microbiol 36:447\u2013456","journal-title":"Mol Microbiol"},{"key":"4423_CR26","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2011-12-3-r29","volume":"12","author":"F Denoeud","year":"2011","unstructured":"Denoeud F, Roussel M, Noel B, Wawrzyniak I, Da Silva C, Diogon M, Viscogliosi E, Brochier-Armanet C, Couloux A, Poulain J, Segurens B, Anthouard V, Texier C, Blot N, Poirier P, Ng GC, Tan KS, Artiguenave F, Jaillon O, Aury JM, Delbac F, Wincker P, Vivar\u00e8s CP, El Alaoui H (2011) Genome sequence of the stramenopile Blastocystis, a human anaerobic parasite. Genome Biol 12:R29. doi: 10.1186\/gb-2011-12-3-r29","journal-title":"Genome Biol"},{"key":"4423_CR27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00436-010-2095-4","volume":"108","author":"EC Dinleyici","year":"2011","unstructured":"Dinleyici EC, Eren M, Dogan N, Reyhanioglu S, Yargic ZA, Vandenplas Y (2011) Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. Parasitol Res 108:541\u2013545. doi: 10.1007\/s00436-010-2095-4","journal-title":"Parasitol Res"},{"key":"4423_CR28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijantimicag.2010.03.004","volume":"36","author":"LA Dunn","year":"2010","unstructured":"Dunn LA, Burgess AG, Krauer KG, Eckmann L, Vanelle P, Crozet MD, Gillin FD, Upcroft P, Upcroft JA (2010) A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro. Int J Antimicrob Agents 36:37\u201342. doi: 10.1016\/j.ijantimicag","journal-title":"Int J Antimicrob Agents"},{"key":"4423_CR29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00436-012-2860-7","volume":"111","author":"LA Dunn","year":"2012","unstructured":"Dunn LA, Tan KS, Vanelle P, Juspin T, Crozet MD, Terme T, Upcroft P, Upcroft JA (2012) Development of metronidazole-resistant lines of Blastocystis sp. Parasitol Res 111:441\u2013450. doi: 10.1007\/s00436-012-2860-7","journal-title":"Parasitol Res"},{"key":"4423_CR30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1471-2334-14-164","volume":"14","author":"D Safadi El","year":"2014","unstructured":"El Safadi D, Gaayeb L, Meloni D, Cian A, Poirier P, Wawrzyniak I, Delbac F, Dabboussi F, Delhaes L, Seck M, Hamze M, Riveau G, Viscogliosi E (2014) Children of Senegal River Basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infect Dis 14:164. doi: 10.1186\/1471-2334-14-164","journal-title":"BMC Infect Dis"},{"key":"4423_CR31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4269\/ajtmh.2007.77.1069","volume":"77","author":"M El-Setouhy","year":"2007","unstructured":"El-Setouhy M, Abd Elaziz KM, Helmy H, Farid HA, Kamal HA, Ramzy RM, Shannon WD, Weil GJ (2007) The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. Am J Trop Med Hyg 77:1069\u20131073","journal-title":"Am J Trop Med Hyg"},{"key":"4423_CR32","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.4269\/ajtmh.2012.11-0761","volume":"87","author":"AL Engsbro","year":"2012","unstructured":"Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P (2012) Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome. Am J Trop Med Hyg 87:1046\u20131052. doi: 10.4269\/ajtmh. 2012.11-0761","journal-title":"Am J Trop Med Hyg"},{"key":"4423_CR33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/00365548.2013.861609","volume":"46","author":"AL Engsbro","year":"2014","unstructured":"Engsbro AL, Stensvold CR, Vedel Nielsen H, Bytzer P (2014) Prevalence, incidence, and risk factors of intestinal parasites in Danish primary care patients with irritable bowel syndrome. Scand J Infect Dis 46:204\u2013209. doi: 10.3109\/00365548.2013.861609","journal-title":"Scand J Infect Dis"},{"key":"4423_CR34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1179\/136485908X267894","volume":"102","author":"AA Escobedo","year":"2008","unstructured":"Escobedo AA, Alvarez G, Gonz\u00e1lez ME, Almirall P, Ca\u00f1ete R, Cimerman S, Ruiz A, P\u00e9rez R (2008) The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide. Ann Trop Med Parasitol 102:199\u2013207","journal-title":"Ann Trop Med Parasitol"},{"key":"4423_CR35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/adc.2008.151852","volume":"94","author":"AA Escobedo","year":"2009","unstructured":"Escobedo AA, Almirall P, Alfonso M, Cimerman S, Rey S, Terry SL (2009) Treatment of intestinal protozoan infections in children. Arch Dis Child 94:478\u2013482. doi: 10.1136\/adc.2008.151852","journal-title":"Arch Dis Child"},{"key":"4423_CR36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/B978-1-4160-4470-3.50083-5","volume-title":"Manson\u2019s tropical diseases","author":"MJG Farthing","year":"2009","unstructured":"Farthing MJG, Cevallos A-M, Kelly P (2009) Intestinal protozoa. In: Cook GC, Zumla AL (eds) Manson\u2019s tropical diseases, 22nd edn. Elsevier, London, pp 1375\u20131406","edition":"22"},{"key":"4423_CR37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/CMR.05038-11","volume":"25","author":"SM Fletcher","year":"2012","unstructured":"Fletcher SM, Stark D, Harkness J, Ellis J (2012) Enteric protozoa in the developed world: a public health perspective. Clin Microbiol Rev 25:420\u2013449. doi: 10.1128\/CMR. 05038-11","journal-title":"Clin Microbiol Rev"},{"key":"4423_CR38","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000320187","volume":"56","author":"T Fujishima","year":"2010","unstructured":"Fujishima T, Nishise S, Ichihara M, Kobayashi S, Takeuchi (2010) Difficulties in the treatment of intestinal amoebiasis in mentally disabled individuals at a rehabilitation institution for the intellectually impaired in Japan. Chemotherapy 56:348\u2013352. doi: 10.1159\/000320187","journal-title":"Chemotherapy"},{"key":"4423_CR39","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.clinthera.2005.12.012","volume":"27","author":"HB Fung","year":"2005","unstructured":"Fung HB, Doan TL (2005) Tinidazole: a nitroimidazole antiprotozoal agent. Clin Ther 27:1859\u20131884","journal-title":"Clin Ther"},{"key":"4423_CR40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/AAC.00614-09","volume":"54","author":"G Gargala","year":"2010","unstructured":"Gargala G, Le Goff L, Ballet JJ, Favennec L, Stachulski AV, Rossignol JF (2010) Evaluation of new thiazolide\/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum. Antimicrob Agents Chemother 54:1315\u20131318. doi: 10.1128\/AAC. 00614-09","journal-title":"Antimicrob Agents Chemother"},{"key":"4423_CR41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vetpar.2006.10.003","volume":"144","author":"M Ghisi","year":"2007","unstructured":"Ghisi M, Kaminsky R, M\u00e4ser P (2007) Phenotyping and genotyping of Haemonchus contortus isolates reveals a new putative candidate mutation for benzimidazole resistance in nematodes. Vet Parasitol 144:313\u2013320","journal-title":"Vet Parasitol"},{"key":"4423_CR42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1469-0691.2003.00504.x","volume":"9","author":"N Girginkarde\u015fler","year":"2003","unstructured":"Girginkarde\u015fler N, Co\u015fkun S, C\u00fcneyt Balcio\u011flu I, Ertan P, Ok UZ (2003) Dientamoeba fragilis, a neglected cause of diarrhea, successfully treated with secnidazole. Clin Microbiol Infect 9:110\u2013113","journal-title":"Clin Microbiol Infect"},{"key":"4423_CR43","first-page":"CD006085","volume":"2","author":"ML Gonzales","year":"2009","unstructured":"Gonzales ML, Dans LF, Martinez EG (2009) Antiamoebic drugs for treating amoebic colitis. Cochrane Database Syst Rev 2:CD006085. doi: 10.1002\/14651858.CD006085.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"4423_CR44","volume":"12","author":"CE Granados","year":"2012","unstructured":"Granados CE, Reveiz L, Uribe LG, Criollo CP (2012) Drugs for treating giardiasis. Cochrane Database Syst Rev 12, CD007787. doi: 10.1002\/14651858.CD007787.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"4423_CR45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/MPG.0b013e31823a29a7","volume":"54","author":"K Heyland","year":"2012","unstructured":"Heyland K, Friedt M, Buehr P, Braegger CP (2012) No advantage for antibiotic treatment over placebo in Blastocystis hominis-positive children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr 54:677\u2013679","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Pt 2","key":"4423_CR46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S0031182005007596","volume":"131","author":"JD Hoevers","year":"2005","unstructured":"Hoevers JD, Snowden KF (2005) Analysis of the ITS region and partial ssu and lsu rRNA genes of Blastocystis and Proteromonas lacertae. Parasitology 131(Pt 2):187\u2013196","journal-title":"Parasitology"},{"key":"4423_CR47","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/AAC.01159-06","volume":"51","author":"PS Hoffman","year":"2007","unstructured":"Hoffman PS, Sisson G, Croxen MA, Welch K, Harman WD, Cremades N, Morash MG (2007) Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob Agents Chemother 51:868\u2013876","journal-title":"Antimicrob Agents Chemother"},{"key":"4423_CR48","first-page":"10","volume":"41","author":"H Hooshyar","year":"2012","unstructured":"Hooshyar H, Rostamkhani P, Rezaian M (2012) Molecular epidemiology of human intestinal amoebas in Iran. Iran J Public Health 41:10\u201317","journal-title":"Iran J Public Health"},{"key":"4423_CR49","doi-asserted-by":"crossref","first-page":"e2758","DOI":"10.1371\/journal.pntd.0002758","volume":"8","author":"PJ Hotez","year":"2014","unstructured":"Hotez PJ (2014) Could nitazoxanide be added to other essential medicines for integrated neglected tropical disease control and elimination? PLoS Negl Trop Dis 8:e2758. doi: 10.1371\/journal.pntd.0002758","journal-title":"PLoS Negl Trop Dis"},{"key":"4423_CR50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.12816\/0006403","volume":"43","author":"SM Hussien","year":"2013","unstructured":"Hussien SM, Abdella OH, Abu-Hashim AH, Aboshiesha GA, Taha MA, El-Shemy AS, El-Bader MM (2013) Comparative study between the effect of nitazoxanide and paromomycine in treatment of cryptosporidiosis in hospitalized children. J Egypt Soc Parasitol 43:463\u2013470","journal-title":"J Egypt Soc Parasitol"},{"key":"4423_CR51","first-page":"704937","volume":"2014","author":"LR Iyer","year":"2014","unstructured":"Iyer LR, Singh N, Verma AK, Paul J (2014) Differential expression and immunolocalization of antioxidant enzymes in Entamoeba histolytica isolates during metronidazole stress. Biomed Res Int 2014:704937. doi: 10.1155\/2014\/704937","journal-title":"Biomed Res Int"},{"key":"4423_CR52","doi-asserted-by":"crossref","first-page":"26889","DOI":"10.1074\/jbc.M110.106310","volume":"285","author":"G Jeelani","year":"2010","unstructured":"Jeelani G, Husain A, Sato D, Ali V, Suematsu M, Soga T, Nozaki T (2010) Two atypical L-cysteine-regulated NADPH-dependent oxidoreductases involved in redox maintenance, L-cystine and iron reduction, and metronidazole activation in the enteric protozoan Entamoeba histolytica. J Biol Chem 285:26889\u201326899. doi: 10.1074\/jbc.M110.106310","journal-title":"J Biol Chem"},{"key":"4423_CR53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00436-009-1363-7","volume":"105","author":"E Jim\u00e9nez-Cardoso","year":"2009","unstructured":"Jim\u00e9nez-Cardoso E, Eligio-Garc\u00eda L, Cort\u00e9s-Campos A, Flores-Luna A, Valencia-Mayoral P, Lozada-Ch\u00e1vez I (2009) Changes in beta-giardin sequence of Giardia intestinalis sensitive and resistant to albendazole strains. Parasitol Res 105:25\u201333. doi: 10.1007\/s00436-009-1363-7","journal-title":"Parasitol Res"},{"key":"4423_CR54","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00436-011-2626-7","volume":"110","author":"DE Jimenez-Gonzalez","year":"2012","unstructured":"Jimenez-Gonzalez DE, Martinez-Flores WA, Reyes-Gordillo J, Ramirez-Miranda ME, Arroyo-Escalante S, Romero-Valdovinos M, Stark D, Souza-Saldivar V, Martinez-Hernandez F, Flisser A, Olivo-Diaz A, Maravilla P (2012) Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res 110:1269\u20131275. doi: 10.1007\/s00436-011-2626-7","journal-title":"Parasitol Res"},{"key":"4423_CR55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4065\/mcp.2011.0203","volume":"86","author":"S Kappagoda","year":"2011","unstructured":"Kappagoda S, Singh U, Blackburn BG (2011) Antiparasitic therapy. Mayo Clin Proc 86:561\u2013583","journal-title":"Mayo Clin Proc"},{"key":"4423_CR56","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1017\/S0031182011000035","volume":"138","author":"P Kelly","year":"2011","unstructured":"Kelly P (2011) Treatment and prevention of cryptosporidiosis: what options are there for a country like Zambia? Parasitology 138:1488\u20131491. doi: 10.1017\/S0031182011000035","journal-title":"Parasitology"},{"key":"4423_CR57","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/CMR.8.3.427","volume":"8","author":"M Khaw","year":"1995","unstructured":"Khaw M, Panosian CB (1995) Human antiprotozoal therapy: past, present, and future. Clin Microbiol Rev 8:427\u2013439","journal-title":"Clin Microbiol Rev"},{"key":"4423_CR58","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.parint.2013.07.004","volume":"62","author":"T Kikuchi","year":"2013","unstructured":"Kikuchi T, Koga M, Shimizu S, Miura T, Maruyama H, Kimura M (2013) Efficacy and safety of paromomycin for treating amebiasis in Japan. Parasitol Int 62:497\u2013501. doi: 10.1016\/j.parint.2013.07.004","journal-title":"Parasitol Int"},{"key":"4423_CR59","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1469-0691.2008.02002.x","volume":"14","author":"O Kurt","year":"2008","unstructured":"Kurt O, Girginkarde\u015fler N, Balcio\u011flu IC, Ozbilgin A, Ok UZ (2008) A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis. Clin Microbiol Infect 14:601\u2013604. doi: 10.1111\/j.1469-0691.2008.02002.x","journal-title":"Clin Microbiol Infect"},{"key":"4423_CR60","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1371\/journal.pbio.0050211","volume":"5","author":"D Leitsch","year":"2007","unstructured":"Leitsch D, Kolarich D, Wilson IB, Altmann F, Duch\u00eane M (2007) Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase. PLoS Biol 5:e211","journal-title":"PLoS Biol"},{"key":"4423_CR61","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/jac\/dkr192","volume":"66","author":"D Leitsch","year":"2011","unstructured":"Leitsch D, Burgess AG, Dunn LA, Krauer KG, Tan K, Duch\u00eane M, Upcroft P, Eckmann L, Upcroft JA (2011) Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia. J Antimicrob Chemother 66:1756\u20131765. doi: 10.1093\/jac\/dkr192","journal-title":"J Antimicrob Chemother"},{"key":"4423_CR62","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/46.5.819","volume":"46","author":"V Lem\u00e9e","year":"2000","unstructured":"Lem\u00e9e V, Zaharia I, Nevez G, Rabodonirina M, Brasseur P, Ballet JJ, Favennec L (2000) Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. J Antimicrob Chemother 46:819\u2013821","journal-title":"J Antimicrob Chemother"},{"key":"4423_CR63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-6851(00)00194-8","volume":"108","author":"SM Liu","year":"2000","unstructured":"Liu SM, Brown DM, O\u2019Donoghue P, Upcroft P, Upcroft JA (2000) Ferredoxin involvement in metronidazole resistance of Giardia duodenalis. Mol Biochem Parasitol 108:137\u2013140","journal-title":"Mol Biochem Parasitol"},{"issue":"Suppl 1","key":"4423_CR64","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/647939","volume":"50","author":"S L\u00f6fmark","year":"2010","unstructured":"L\u00f6fmark S, Edlund C, Nord CE (2010) Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 50(Suppl 1):S16\u2013S23. doi: 10.1086\/647939","journal-title":"Clin Infect Dis"},{"key":"4423_CR65","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.1074\/jbc.M211757200","volume":"278","author":"C L\u00f3pez-Camarillo","year":"2003","unstructured":"L\u00f3pez-Camarillo C, Luna-Arias JP, Marchat LA, Orozco E (2003) EhPgp5 mRNA stability is a regulatory event in the Entamoeba histolytica multidrug resistance phenotype. J Biol Chem 278:11273\u201311280","journal-title":"J Biol Chem"},{"key":"4423_CR66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4269\/ajtmh.2010.09-0742","volume":"83","author":"R Lopez-Velez","year":"2010","unstructured":"Lopez-Velez R, Batlle C, Jim\u00e9nez C, Navarro M, Norman F, Perez-Molina J (2010) Short course combination therapy for giardiasis after nitroimidazole failure. Am J Trop Med Hyg 83:171\u2013173. doi: 10.4269\/ajtmh. 2010.09-0742","journal-title":"Am J Trop Med Hyg"},{"key":"4423_CR67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molbiopara.2004.08.001","volume":"138","author":"LM MacDonald","year":"2004","unstructured":"MacDonald LM, Armson A, Thompson AR, Reynoldson JA (2004) Characterisation of benzimidazole binding with recombinant tubulin from Giardia duodenalis, Encephalitozoon intestinalis, and Cryptosporidium parvum. Mol Biochem Parasitol 138:89\u201396","journal-title":"Mol Biochem Parasitol"},{"key":"4423_CR68","unstructured":"Mackey-Lawrence NM, Petri WA Jr (2011) Amoebic dysentery. BMJ Clin Evid"},{"key":"4423_CR69","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/AAC.00900-10","volume":"55","author":"H Mirza","year":"2011","unstructured":"Mirza H, Teo JD, Upcroft J, Tan KS (2011) A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities. Antimicrob Agents Chemother 55:637\u2013648. doi: 10.1128\/AAC. 00900-10","journal-title":"Antimicrob Agents Chemother"},{"key":"4423_CR70","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jinf.2008.01.013","volume":"56","author":"K M\u00f8rch","year":"2008","unstructured":"M\u00f8rch K, Hanevik K, Robertson LJ, Strand EA, Langeland N (2008) Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. J Infect 56:268\u2013273. doi: 10.1016\/j.jinf.2008.01.013","journal-title":"J Infect"},{"key":"4423_CR71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/AAC.50.1.162-170.2006","volume":"50","author":"J M\u00fcller","year":"2006","unstructured":"M\u00fcller J, R\u00fchle G, M\u00fcller N, Rossignol JF, Hemphill A (2006) In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells. Antimicrob Agents Chemother 50:162\u2013170","journal-title":"Antimicrob Agents Chemother"},{"key":"4423_CR72","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jac\/dkm205","volume":"60","author":"J M\u00fcller","year":"2007","unstructured":"M\u00fcller J, Sterk M, Hemphill A, M\u00fcller N (2007a) Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother 60:280\u2013287","journal-title":"J Antimicrob Chemother"},{"key":"4423_CR73","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/AAC.01548-06","volume":"51","author":"J M\u00fcller","year":"2007","unstructured":"M\u00fcller J, Wastling J, Sanderson S, M\u00fcller N, Hemphill A (2007b) A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides. Antimicrob Agents Chemother 51:1979\u20131986","journal-title":"Antimicrob Agents Chemother"},{"key":"4423_CR74","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jac\/dkn142","volume":"62","author":"J M\u00fcller","year":"2008","unstructured":"M\u00fcller J, Ley S, Felger I, Hemphill A, M\u00fcller N (2008) Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole. J Antimicrob Chemother 62:72\u201382. doi: 10.1093\/jac\/dkn142","journal-title":"J Antimicrob Chemother"},{"key":"4423_CR75","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/jac\/dkt106","volume":"68","author":"J M\u00fcller","year":"2013","unstructured":"M\u00fcller J, Schildknecht P, M\u00fcller N (2013) Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2). Antimicrob Chemother 68:1781\u20131789. doi: 10.1093\/jac\/dkt106","journal-title":"Antimicrob Chemother"},{"key":"4423_CR76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tmaid.2012.10.004","volume":"11","author":"J Mu\u00f1oz Guti\u00e9rrez","year":"2013","unstructured":"Mu\u00f1oz Guti\u00e9rrez J, Aldasoro E, Requena A, Comin AM, Pinazo MJ, Bardaj\u00ed A, Oliveira I, Valls ME, Gascon J (2013) Refractory giardiasis in Spanish travellers. Travel Med Infect Dis 11:126\u2013129. doi: 10.1016\/j.tmaid.2012.10.004","journal-title":"Travel Med Infect Dis"},{"key":"4423_CR77","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1756-3305-5-182","volume":"5","author":"PN Mwinzi","year":"2012","unstructured":"Mwinzi PN, Montgomery SP, Owaga CO, Mwanje M, Muok EM, Ayisi JG, Laserson KF, Muchiri EM, Secor WE, Karanja DM (2012) Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya\u2014a pilot study. Parasit Vectors 5:182","journal-title":"Parasit Vectors"},{"key":"4423_CR78","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/AAC.05125-11","volume":"56","author":"N Nagata","year":"2012","unstructured":"Nagata N, Marriott D, Harkness J, Ellis JT, Stark D (2012) In vitro susceptibility testing of Dientamoeba fragilis. Antimicrob Agents Chemother 56:487\u2013494. doi: 10.1128\/AAC. 05125-11","journal-title":"Antimicrob Agents Chemother"},{"key":"4423_CR79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1086\/320886","volume":"33","author":"TE Nash","year":"2001","unstructured":"Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA (2001) Treatment of patients with refractory giardiasis. Clin Infect Dis 33:22\u201328","journal-title":"Clin Infect Dis"},{"key":"4423_CR80","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1756-3305-5-187","volume":"5","author":"R Ngui","year":"2012","unstructured":"Ngui R, Angal L, Fakhrurrazi SA, Lian YL, Ling LY, Ibrahim J, Mahmud R (2012) Differentiating Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii using nested polymerase chain reaction (PCR) in rural communities in Malaysia. Parasit Vectors 5:187","journal-title":"Parasit Vectors"},{"key":"4423_CR81","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2310\/7060.2003.31714","volume":"10","author":"L Nigro","year":"2003","unstructured":"Nigro L, Larocca L, Massarelli L, Patamia I, Minniti S, Palermo F, Cacopardo B (2003) A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med 10:128\u2013130","journal-title":"J Travel Med"},{"key":"4423_CR82","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/jac\/dkr029","volume":"66","author":"D Nillius","year":"2011","unstructured":"Nillius D, M\u00fcller J, M\u00fcller N (2011) Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs. Antimicrob Chemother 66:1029\u20131035. doi: 10.1093\/jac\/dkr029","journal-title":"Antimicrob Chemother"},{"key":"4423_CR83","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1046\/j.1365-3156.2001.00777.x","volume":"6","author":"M Ouellette","year":"2001","unstructured":"Ouellette M (2001) Biochemical and molecular mechanisms of drug resistance in parasites. Trop Med Int Health 6:874\u2013882","journal-title":"Trop Med Int Health"},{"key":"4423_CR84","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/0036554021000026962","volume":"34","author":"A Ozbilgin","year":"2002","unstructured":"Ozbilgin A, Ertan P, Yereli K, Tamay AT, Kurt O, Degerli K, Balcioglu IC, Ok UZ, Onag A (2002) Giardiasis treatment in Turkish children with a single dose of ornidazole. Scand J Infect Dis 34:918\u2013920","journal-title":"Scand J Infect Dis"},{"key":"4423_CR85","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/AAC.00909-08","volume":"53","author":"D Pal","year":"2009","unstructured":"Pal D, Banerjee S, Cui J, Schwartz A, Ghosh SK, Samuelson J (2009) Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases). Antimicrob Agents Chemother 53:458\u2013464. doi: 10.1128\/AAC. 00909-08","journal-title":"Antimicrob Agents Chemother"},{"key":"4423_CR86","doi-asserted-by":"crossref","first-page":"e2733","DOI":"10.1371\/journal.pntd.0002733","volume":"8","author":"V Pasupuleti","year":"2014","unstructured":"Pasupuleti V, Escobedo AA, Deshpande A, Thota P, Roman Y, Hernandez AV (2014) Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials. PLoS Negl Trop Dis 8:e2733. doi: 10.1371\/journal.pntd.0002733","journal-title":"PLoS Negl Trop Dis"},{"key":"4423_CR87","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.meegid.2012.08.021","volume":"15","author":"MT Paz-Maldonado","year":"2013","unstructured":"Paz-Maldonado MT, Arg\u00fcello-Garc\u00eda R, Cruz-Soto M, Mendoza-Hern\u00e1ndez G, Ortega-Pierres G (2013) Proteomic and transcriptional analyses of genes differentially expressed in Giardia duodenalis clones resistant to albendazole. Infect Genet Evol 15:10\u201317. doi: 10.1016\/j.meegid.2012.08.021","journal-title":"Infect Genet Evol"},{"key":"4423_CR88","doi-asserted-by":"crossref","first-page":"O135","DOI":"10.1111\/1469-0691.12327","volume":"20","author":"A Requena-M\u00e9ndez","year":"2014","unstructured":"Requena-M\u00e9ndez A, Go\u00f1i P, L\u00f3bez S, Oliveira I, Aldasoro E, Valls ME, Clavel A, Gasc\u00f3n J, Mu\u00f1oz J (2014) A family cluster of giardiasis with variable treatment responses: refractory giardiasis in a family after a trip to India. Clin Microbiol Infect 20:O135\u2013O138. doi: 10.1111\/1469-0691.12327","journal-title":"Clin Microbiol Infect"},{"key":"4423_CR89","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10096-012-1746-z","volume":"32","author":"T Roberts","year":"2013","unstructured":"Roberts T, Stark D, Harkness J, Ellis J (2013) Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis. Eur J Clin Microbiol Infect Dis 32:335\u2013343. doi: 10.1007\/s10096-012-1746-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4423_CR90","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1099\/jmm.0.065508-0","volume":"63","author":"T Roberts","year":"2014","unstructured":"Roberts T, Ellis J, Harkness J, Marriott D, Stark D (2014) Treatment failure in patients with chronic Blastocystis infection. J Med Microbiol 63:252\u2013257. doi: 10.1099\/jmm. 0.065508-0","journal-title":"J Med Microbiol"},{"key":"4423_CR91","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.exppara.2009.07.005","volume":"124","author":"JF Rossignol","year":"2010","unstructured":"Rossignol JF (2010) Cryptosporidium and Giardia: treatment options and prospects for new drugs. Exp Parasitol 124:45\u201353. doi: 10.1016\/j.exppara.2009.07.005","journal-title":"Exp Parasitol"},{"key":"4423_CR92","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/322038","volume":"184","author":"JF Rossignol","year":"2001","unstructured":"Rossignol JF, Ayoub A, Ayers MS (2001) Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 184:381\u2013384","journal-title":"J Infect Dis"},{"key":"4423_CR93","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1542-3565(05)00427-1","volume":"3","author":"JF Rossignol","year":"2005","unstructured":"Rossignol JF, Kabil SM, Said M, Samir H, Younis AM (2005) Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol 3:987\u2013991","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4423_CR94","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.trstmh.2007.04.001","volume":"101","author":"JF Rossignol","year":"2007","unstructured":"Rossignol JF, Kabil SM, El-Gohary Y, Younis AM (2007) Nitazoxanide in the treatment of amoebiasis. Trans R Soc Trop Med Hyg 101:1025\u20131031","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4423_CR95","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.trstmh.2011.11.007","volume":"106","author":"JF Rossignol","year":"2012","unstructured":"Rossignol JF, Lopez-Chegne N, Julcamoro LM, Carrion ME, Bardin MC (2012) Nitazoxanide for the empiric treatment of pediatric infectious diarrhea. Trans R Soc Trop Med Hyg 106:167\u2013173. doi: 10.1016\/j.trstmh.2011.11.007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4423_CR96","first-page":"80","volume":"3","author":"JM Salles","year":"1999","unstructured":"Salles JM, Bechara C, Tavares AM, Martins M, Sobrinho JG, Dietrich-Neto F, Costa VV (1999) Comparative study of the efficacy and tolerability of secnidazole suspension (single dose) and tinidazole suspension (two days dosage) in the treatment of amebiasis in children. Braz J Infect Dis 3:80\u201388","journal-title":"Braz J Infect Dis"},{"key":"4423_CR97","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/jac\/40.6.833","volume":"40","author":"NA Samarawickrema","year":"1997","unstructured":"Samarawickrema NA, Brown DM, Upcroft JA, Thammapalerd N, Upcroft P (1997) Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. J Antimicrob Chemother 40:833\u2013840","journal-title":"J Antimicrob Chemother"},{"key":"4423_CR98","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pt.2006.02.015","volume":"22","author":"L Savioli","year":"2006","unstructured":"Savioli L, Smith H, Thompson A (2006) Giardia and Cryptosporidium join the \u2018Neglected Diseases Initiative\u2019. Trends Parasitol 22:203\u2013208","journal-title":"Trends Parasitol"},{"key":"4423_CR99","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/BJ20121798","volume":"451","author":"S Schlosser","year":"2013","unstructured":"Schlosser S, Leitsch D, Duch\u00eane M (2013) Entamoeba histolytica: identification of thioredoxin-targeted proteins and analysis of serine acetyltransferase-1 as a prototype example. Biochem J 451:277\u2013288. doi: 10.1042\/BJ20121798","journal-title":"Biochem J"},{"key":"4423_CR100","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1097\/INF.0b013e31827f4c20","volume":"32","author":"JM Schure","year":"2013","unstructured":"Schure JM, de Vries M, Weel JF, van Roon EN, Faber TE (2013) Symptoms and treatment of Dientamoeba fragilis infection in children, a retrospective study. Pediatr Infect Dis J 32:e148\u2013e150. doi: 10.1097\/INF.0b013e31827f4c20","journal-title":"Pediatr Infect Dis J"},{"key":"4423_CR101","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/CMR.00021-08","volume":"21","author":"FL Schuster","year":"2008","unstructured":"Schuster FL, Ramirez-Avila L (2008) Current world status of Balantidium coli. Clin Microbiol Rev 21:626\u2013638. doi: 10.1128\/CMR. 00021-08","journal-title":"Clin Microbiol Rev"},{"key":"4423_CR102","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00436-013-3394-3","volume":"112","author":"G Shukla","year":"2013","unstructured":"Shukla G, Kaur H, Sharma L (2013) Comparative therapeutic effect of probiotic Lactobacillus casei alone and in conjunction with antiprotozoal drugs in murine giardiasis. Parasitol Res 112:2143\u20132149. doi: 10.1007\/s00436-013-3394-3","journal-title":"Parasitol Res"},{"key":"4423_CR103","doi-asserted-by":"crossref","first-page":"e682","DOI":"10.1371\/journal.pntd.0000682","volume":"4","author":"S Solaymani-Mohammadi","year":"2010","unstructured":"Solaymani-Mohammadi S, Genkinger JM, Loffredo CA, Singer SM (2010) A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis. PLoS Negl Trop Dis 4:e682. doi: 10.1371\/journal.pntd.0000682","journal-title":"PLoS Negl Trop Dis"},{"key":"4423_CR104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-3305-6-3","volume":"6","author":"B Speich","year":"2013","unstructured":"Speich B, Marti H, Ame SM, Ali SM, Bogoch II, Utzinger J, Albonico M, Keiser J (2013) Prevalence of intestinal protozoa infection among school-aged children on Pemba Island, Tanzania, and effect of single-dose albendazole, nitazoxanide and albendazole-nitazoxanide. Parasit Vectors 6:3. doi: 10.1186\/1756-3305-6-3","journal-title":"Parasit Vectors"},{"key":"4423_CR105","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.4081\/idr.2009.1280","volume":"1","author":"D Stark","year":"2009","unstructured":"Stark D, Barratt J, Ellis J, Harkness J, Marriott D (2009) Repeated Dientamoeba fragilis infections: a case report of two families from Sydney, Australia. Infect Dis Rep 1:e4. doi: 10.4081\/idr.2009.e4","journal-title":"Infect Dis Rep"},{"key":"4423_CR106","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4269\/ajtmh.2010.09-0478","volume":"82","author":"D Stark","year":"2010","unstructured":"Stark D, Barratt J, Roberts T, Marriott D, Harkness J, Ellis J (2010) A review of the clinical presentation of dientamoebiasis. Am J Trop Med Hyg 82:614\u2013619. doi: 10.4269\/ajtmh. 2010.09-0478","journal-title":"Am J Trop Med Hyg"},{"key":"4423_CR107","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJMoa1103360","volume":"366","author":"SJ Swanson","year":"2012","unstructured":"Swanson SJ, Phares CR, Mamo B, Smith KE, Cetron MS, Stauffer WM (2012) Albendazole therapy and enteric parasites in United States-bound refugees. N Engl J Med 366:1498\u20131507. doi: 10.1056\/NEJMoa1103360","journal-title":"N Engl J Med"},{"key":"4423_CR108","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3923\/jms.2006.378.381","volume":"6","author":"SA Talari","year":"2006","unstructured":"Talari SA, Momtazmanesh N, Talebian A, Khorshidi A, Taghavi A, Fakharian E, Talari MR, Mokhtari Z (2006) Comparison of metronidazole and furazolidone against Giardia lamblia in children. J Med Sci 6:378\u2013381. doi: 10.3923\/jms.2006.378.381","journal-title":"J Med Sci"},{"key":"4423_CR109","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.exppara.2008.09.011","volume":"120","author":"M Tazreiter","year":"2008","unstructured":"Tazreiter M, Leitsch D, Hatzenbichler E, Mair-Scorpio GE, Steinborn R, Schreiber M, Duch\u00eane M (2008) Entamoeba histolytica: response of the parasite to metronidazole challenge on the levels of mRNA and protein expression. Exp Parasitol 120:403\u2013410. doi: 10.1016\/j.exppara.2008.09.011","journal-title":"Exp Parasitol"},{"key":"4423_CR110","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1128\/AAC.00384-11","volume":"55","author":"N Tejman-Yarden","year":"2011","unstructured":"Tejman-Yarden N, Millman M, Lauwaet T, Davids BJ, Gillin FD, Dunn L, Upcroft JA, Miyamoto Y, Eckmann L (2011) Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia. Antimicrob Agents Chemother 55:4643\u20134651. doi: 10.1128\/AAC. 00384-11","journal-title":"Antimicrob Agents Chemother"},{"key":"4423_CR111","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1021\/jm900356n","volume":"52","author":"CA Valdez","year":"2009","unstructured":"Valdez CA, Tripp JC, Miyamoto Y, Kalisiak J, Hruz P, Andersen YS, Brown SE, Kangas K, Arzu LV, Davids BJ, Gillin FD, Upcroft JA, Upcroft P, Fokin VV, Smith DK, Sharpless KB, Eckmann L (2009) Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia. J Med Chem 52:4038\u20134053. doi: 10.1021\/jm900356n","journal-title":"J Med Chem"},{"key":"4423_CR112","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpddr.2012.03.002","volume":"2","author":"JJ Hellemond van","year":"2012","unstructured":"van Hellemond JJ, Molhoek N, Koelewijn R, Wismans PJ, van Genderen PJ (2012) Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults? Int J Parasitol Drugs Drug Resist 2:162\u2013165. doi: 10.1016\/j.ijpddr.2012.03.002","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"4423_CR113","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10156-012-0496-2","volume":"19","author":"JJ Hellemond van","year":"2013","unstructured":"van Hellemond JJ, Molhoek N, Koelewijn R, Wismans PJ, van Genderen PJ (2013) Is paromomycin the drug of choice for eradication of Blastocystis in adults? J Infect Chemother 19:545\u2013548. doi: 10.1007\/s10156-012-0496-2","journal-title":"J Infect Chemother"},{"key":"4423_CR114","doi-asserted-by":"crossref","first-page":"885","DOI":"10.7326\/0003-4819-132-11-200006060-00006","volume":"132","author":"RI Verdier","year":"2000","unstructured":"Verdier RI, Fitzgerald DW, Johnson WD Jr, Pape JW (2000) Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. Ann Intern Med 132:885\u2013888","journal-title":"Ann Intern Med"},{"key":"4423_CR115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.parint.2010.03.009","volume":"59","author":"C Vogelberg","year":"2010","unstructured":"Vogelberg C, Stensvold CR, Monecke S, Ditzen A, Stopsack K, Heinrich-Gr\u00e4fe U, P\u00f6hlmann C (2010) Blastocystis sp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms. Parasitol Int 59:469\u2013471. doi: 10.1016\/j.parint.2010.03.009","journal-title":"Parasitol Int"},{"key":"4423_CR116","doi-asserted-by":"crossref","first-page":"26051","DOI":"10.1074\/jbc.274.37.26051","volume":"274","author":"C Wassman","year":"1999","unstructured":"Wassman C, Hellberg A, Tannich E, Bruchhaus I (1999) Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J Biol Chem 274:26051\u201326056","journal-title":"J Biol Chem"},{"key":"4423_CR117","unstructured":"WHO (2014) Antimicrobial resistance: global report on surveillance"},{"key":"4423_CR118","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/138161208784041105","volume":"14","author":"J Wiesner","year":"2008","unstructured":"Wiesner J, Reichenberg A, Heinrich S, Schlitzer M, Jomaa H (2008) The plastid-like organelle of apicomplexan parasites as drug target. Curr Pharm Des 14:855\u2013871","journal-title":"Curr Pharm Des"},{"key":"4423_CR119","doi-asserted-by":"crossref","first-page":"e2885","DOI":"10.1371\/journal.pntd.0002885","volume":"8","author":"Z Wu","year":"2014","unstructured":"Wu Z, Mirza H, Tan KS (2014) Intra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7. PLoS Negl Trop Dis 8:e2885. doi: 10.1371\/journal.pntd.0002885","journal-title":"PLoS Negl Trop Dis"},{"key":"4423_CR120","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00436-010-1918-7","volume":"107","author":"J Yakoob","year":"2010","unstructured":"Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R (2010) Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 107:679\u2013684. doi: 10.1007\/s00436-010-1918-7","journal-title":"Parasitol Res"},{"key":"4423_CR121","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/510744","volume":"44","author":"SM Zimmer","year":"2007","unstructured":"Zimmer SM, Schuetz AN, Franco-Paredes C (2007) Efficacy of nitazoxanide for cyclosporiasis in patients with sulfa allergy. Clin Infect Dis 44:466\u2013467","journal-title":"Clin Infect Dis"},{"key":"4423_CR122","doi-asserted-by":"crossref","first-page":"e2553","DOI":"10.1371\/journal.pntd.0002553","volume":"7","author":"JL Zumaquero-R\u00edos","year":"2013","unstructured":"Zumaquero-R\u00edos JL, Sarracent-P\u00e9rez J, Rojas-Garc\u00eda R, Rojas-Rivero L, Mart\u00ednez-Tovilla Y, Valero MA, Mas-Coma S (2013) Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanide. PLoS Negl Trop Dis 7:e2553","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-015-4423-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-015-4423-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-015-4423-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T07:00:26Z","timestamp":1651561226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-015-4423-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,19]]},"references-count":122,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["4423"],"URL":"https:\/\/doi.org\/10.1007\/s00436-015-4423-1","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,19]]}}}